RECRUITING

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).

Official Title

A Feasibility Study of Orchiectomy in Patients With Prostate Cancer on Chronic LHRH Agonist or Antagonist Therapy

Quick Facts

Study Start:2020-12-18
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04705038

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of metastatic prostatic adenocarcinoma
  2. * Receiving luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist therapy continuously for at least 1 year with anticipated lifelong therapy
  3. * Able to complete written surveys in English
  1. * More than 2 prior systemic treatment regimens utilized in addition to castration.

Contacts and Locations

Study Contact

Personalized Cancer Care Consortium
CONTACT
773.702.1220
PhaseIICRA@medicine.bsd.uchicago.edu

Principal Investigator

Walter Stadler, MD
STUDY_CHAIR
University of Chicago

Study Locations (Sites)

University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois, 60637
United States

Collaborators and Investigators

Sponsor: University of Chicago

  • Walter Stadler, MD, STUDY_CHAIR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-18
Study Completion Date2025-12

Study Record Updates

Study Start Date2020-12-18
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Cancer